Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1450 of 3284 entries
View as:

Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00044694 Org: User:
Start: 08/31/02 End: 05/31/03 Due: 05/31/04

HRR Prevalence in LatAm PROSPECT Study

Phase: N/A Priority: Normal
NCT ID: NCT04962880 Org: User:
Start: 04/21/21 End: 04/08/22 Due: 04/08/23

Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04673630 Org: User:
Start: 02/23/21 End: 09/27/22 Due: 09/27/23

Non-interventional Open Label Study to Investigate the Effect of Quetiapine XR on Patient Satisfaction and Quality of Life in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00934726 Org: User:
Start: 07/31/09 End: 10/31/10 Due: 10/31/11

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00103935 Org: User:
Start: 02/28/05 End: 10/31/05 Due: 10/31/06

PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin

Phase: N/A Priority: Normal
NCT ID: NCT00355615 Org: User:
Start: 07/31/06 End: 07/31/08 Due: 07/31/09

AZD2066 Neuropathic Pain - Mechanical Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT00939094 Org: User:
Start: 08/31/09 End: 11/30/10 Due: 11/30/11

Assessment of Asthma Control Level in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT03295331 Org: User:
Start: 01/03/17 End: 04/05/17 Due: 04/05/18

ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)

Phase: N/A Priority: Normal
NCT ID: NCT00229684 Org: User:
Start: 09/30/04 End: 06/30/06 Due: 06/30/07

Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT02477475 Org: User:
Start: 07/07/15 End: 02/20/17 Due: 02/20/18

Esomeprazole for Treatment of GERD in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT00228527 Org: User:
Start: 10/31/04 End: 10/31/05 Due: 10/31/06

A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01096563 Org: User:
Start: 03/31/10 End: 06/30/10 Due: 06/30/11

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Phase: N/A Priority: Normal
NCT ID: NCT01002807 Org: User:
Start: 11/30/09 End: 01/31/10 Due: 01/31/11

Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal

Phase: N/A Priority: Normal
NCT ID: NCT00905333 Org: User:
Start: 10/31/08 End: 11/30/08 Due: 11/30/09

Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402

Phase: N/A Priority: Normal
NCT ID: NCT03921268 Org: User:
Start: 03/25/19 End: 06/13/19 Due: 06/13/20

Correlation Between Patient Perception and Findings on Clinical Examination in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01703416 Org: User:
Start: 10/31/12 End: 04/30/13 Due: 04/30/14

AZD6280 Multiple Ascending Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT00681317 Org: User:
Start: 03/31/08 End: 07/31/08 Due: 07/31/09

Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Phase: N/A Priority: Normal
NCT ID: NCT00973076 Org: User:
Start: 08/31/09 End: 12/31/10 Due: 12/31/11

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00787410 Org: User:
Start: 09/30/03 End: 04/30/08 Due: 04/30/09

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Settings

Phase: N/A Priority: Normal
NCT ID: NCT02322762 Org: User:
Start: 12/30/14 End: 08/21/19 Due: 08/21/20

A Study to Assess the Impact of Multiple Doses of AZD6234 on a Single Dose of Combined Oral Contraceptive in Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT07013643 Org: User:
Start: 06/04/25 End: 01/07/26 Due: 01/07/27

Inhaled Steroid Treatment as Regular Therapy in Early Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00641914 Org: User:
Start: 10/31/96 End: 02/28/03 Due: 02/28/04

Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect

Phase: N/A Priority: Normal
NCT ID: NCT00534222 Org: User:
Start: 09/30/05 End: 12/31/07 Due: 12/31/08

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

Phase: N/A Priority: Normal
NCT ID: NCT00286117 Org: User:
Start: 03/31/98 End: 05/31/06 Due: 05/31/07

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

Phase: N/A Priority: Normal
NCT ID: NCT03875235 Org: User:
Start: 04/16/19 End: 12/31/25 Due: 12/31/26